
MASSDEVICE ON CALL — Renal denervation, studied primarily in treatment of hypertension, may product benefits to heart health independent of those generated by lowering blood pressure, according to researchers reporting results from a small study.
The clinicians cautioned that the results are very early and need confirmation from a larger study, but were worked up about the findings.
"It’s an exciting, provocative result, and there’s a good chance that it will stand the test of time, but I still think in general, it’s best to be cautious about new technologies and relatively small studies, because time typically shows that they provide an overestimate of what the true effects will be," Harvard Medical School’s Dr. Deepak Bhatt told Medscape. "Whether the reduction in left-ventricular mass is beyond what would be anticipated with blood-pressure and heart-rate reduction – certainly this analysis suggests that is a possibility – needs to be confirmed in larger studies."
Healthcare tech inspires global optimism as patients prepare for a paradigm shift
More than 80% of the 12,000 people surveyed said that they see a rosy future in healthcare innovation and more than half think that advancements in technology will one day render hospitals obsolete.
Read more
Researchers reported "substantial" weight-loss sustained out to 3 years for bariatric surgery patients who were severely obese, but cautioned of variability in amount of weight lost, diabetes, blood pressure and other factors.
Read more
A Dutch couple won the Ureka Mega Challenge Award of the University Medical Centre Utrecht by inventing a scalp-cooling cap designed to help prevent hair-loss associated with chemotherapy.
Read more
The Senate Finance Committee is scheduled this Thursday to vote on a measure that could be a longer-term solution to the annual hand-wringing over cuts in Medicare fees paid to doctors. Congress may pass a 3-month resolution to delay the cuts ahead of a permanent solution, according to reports.
Read more